文献速递外周动脉疾病

就诊时肢体严重程度与慢性肢体威胁性缺血膝下血运重建术后长期结局相关

Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2022-12-27

单中心回顾性研究纳入413例因慢性肢体威胁性缺血行膝下血运重建的患者,按就诊时WIfI分期分析。WIfI 4期与主要截肢(HR 2.3)和死亡(HR 1.6)独立相关,非自体静脉旁路与主要截肢独立相关(HR 2.9)。作者认为就诊WIfI分期应被用于分层结局比较。

要点

  • WIfI 4期与主要截肢(HR 2.3)和死亡(HR 1.6)独立相关。
  • 非自体静脉旁路与主要截肢独立相关(HR 2.9)。
  • WIfI 4期亚组中,腔内血运重建与主要截肢独立相关(HR 2.6)。

核心结论

  • 就诊时WIfI分期与慢性肢体威胁性缺血膝下血运重建术后主要截肢和死亡的长期风险强烈相关,应被用于分层结局比较。
  • 作者认为对WIfI 4期病变进行有效血运重建至关重要,自体静脉旁路提供持久的长期保肢效果。

研究设计与样本

  • 单机构回顾性研究,纳入2011年至2021年因慢性肢体威胁性缺血行膝下血运重建且有WIfI分期数据的413例患者。
  • 从电子病历收集患者特征和结局,按就诊时WIfI分期和本中心初始治疗进行分析。

主要发现

  • 就诊时WIfI分期为1至2期占23%,3期占27%,4期占50%。
  • 索引血运重建方式为腔内(59%)、自体静脉旁路(29%)或非自体旁路(13%)。
  • 30天内手术死亡率为2.9%,与WIfI分期或血运重建方式无关。
  • 肢体随访中位时间为502天(四分位距112-1256天),生存随访中位时间为932天(四分位距343-1770天)。
  • 主要截肢或死亡分别发生于19%和46%的患者,中位时间分别为119天(四分位距28-314天)和739天(四分位距204-1475天)。

关键数值与推荐

  • WIfI分期与主要截肢独立相关(P = .001),初始血运重建方式亦与主要截肢独立相关(P = .01)。
  • 主要截肢独立相关因素:男性(HR 1.4;95%CI 1.04-2.0;P = .03)、糖尿病(HR 1.8;95%CI 1.3-2.5;P = .001)、WIfI 4期(HR 2.3;95%CI 1.5-3.5;P < .001)、非自体旁路(HR 2.9;95%CI 2.1-4.2;P < .001)。
  • 死亡独立相关因素:年龄(HR 1.04;95%CI 1.02-1.05;P < .001)、终末期肾病(HR 2.8;95%CI 1.9-4.0;P < .001)、充血性心力衰竭(HR 1.9;95%CI 1.4-2.5;P < .001)、慢性阻塞性肺疾病(HR 1.5;95%CI 1.1-2.1;P = .02)、WIfI 4期(HR 1.6;95%CI 1.04-2.2;P = .03)。
  • WIfI 4期肢体中,Kaplan-Meier估计2年免于主要截肢率和免于死亡率分别为71%±3.7%和68%±3.5%。
  • WIfI 4期亚组逆概率加权Cox模型:非白人种族(HR 1.5;95%CI 1.01-2.2;P = .047)、糖尿病(HR 2.0;95%CI 1.2-3.3;P = .008)、Global Anatomic Staging System膝下分级(HR 1.2;95%CI 1.05-1.3;P = .005)、非自体旁路(HR 3.2;95%CI 1.9-5.3;P < .001)、腔内血运重建(HR 2.6;95%CI 1.6-4.3;P < .001)与主要截肢独立相关。

临床怎么用

  • 作者认为就诊时WIfI分期应被用于分层结局比较。
  • 作者认为对WIfI 4期病变进行有效血运重建至关重要,自体静脉旁路提供持久的长期保肢效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The SVS Wound, Ischemia, foot Infection (WIfI) limb staging system was established to estimate risk of major amputation in chronic limb-threatening ischemia (CLTI) and better stratify outcomes comparisons. There is little data on treatment outcomes beyond 1 year based on presenting WIfI stage. METHODS: This is a single-institution retrospective study of 413 patients who underwent infrainguinal revascularization for CLTI (2011-2021) with data available for WIfI staging. Patient characteristics and outcomes were gathered from the electronic medical record. Data were analyzed based on presenting WIfI stage and initial treatment received at our center. RESULTS: Presenting WIfI stages were 1 to 2 (23%), 3 (27%), and 4 (50%). Index revascularization approach was endoluminal (59%), autogenous vein bypass (29%), or non-autogenous bypass (13%). Operative mortality within 30 days was 2.9% and was not associated with WIfI stage or revascularization approach. Median limb follow-up time was 502 days (interquartile range [IQR], 112-1256 days), and median survival follow-up time was 932 days (IQR, 343-1770 days). Major amputation or death occurred in 19% and 46% of patients at median times of 119 days (IQR, 28-314 days) and 739 days (IQR, 204-1475 days), respectively. WIfI stage was independently associated with major amputation (P = .001), as was initial revascularization approach (P = .01). In a Cox proportional hazards model, factors independently associated with major amputation were male sex (hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.04-2.0; P = .03), diabetes (HR, 1.8; 95% CI, 1.3-2.5; P = .001), WIfI stage 4 (HR, 2.3; 95% CI, 1.5-3.5; P < .001), and non-autogenous bypass (HR, 2.9; 95% CI, 2.1-4.2; P < .001). In a Cox proportional hazards model for mortality, independently associated factors were age (HR, 1.04; 95% CI, 1.02-1.05; P < .001), end-stage renal disease (HR, 2.8; 95% CI, 1.9-4.0; P < .001), congestive heart failure (HR, 1.9; 95% CI, 1.4-2.5; P < .001), chronic obstructive pulmonary disease (HR, 1.5; 95% CI, 1.1-2.1; P = .02), and WIfI stage 4 (HR, 1.6; 95% CI, 1.04-2.2; P = .03). Among those presenting with WIfI stage 4 limbs, Kaplan-Meier estimated rates of freedom from major amputation or death at 2 years were 71% ± 3.7% and 68% ± 3.5%, respectively. In an inverse propensity weighted Cox proportional hazards model, non-white race (HR, 1.5; 95% CI, 1.01-2.2; P = .047), diabetes (HR, 2.0; 95% CI, 1.2-3.3; P = .008), Global Anatomic Staging System infrapopliteal grade (HR, 1.2; 95% CI, 1.05-1.3; P = .005), non-autogenous bypass (HR, 3.2; 95% CI, 1.9-5.3; P < .001), and endoluminal revascularization (HR, 2.6; 95% CI, 1.6-4.3; P < .001) were independently associated with major amputation in the WIfI stage 4 subgroup. CONCLUSIONS: Presenting WIfI stage is strongly associated with long-term risks of major amputation and death following infrainguinal revascularization for CLTI and should be used to stratify outcomes comparisons. Effective revascularization is critical in WIfI stage 4 disease, and autogenous vein bypass provides durable long-term limb preservation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Liu IH, El Khoury R, Wu B, et al. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2022. PMID: 36584906. doi:10.1016/j.jvs.2022.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。